[87] Two patients with necrobiosis lipoidica were treated for 8 weeks with 0.1% tacrolimus ointment twice daily; one showed a considerable reduction of the inflammation and regression of the ...

Tacrolimus is an immunosuppressant frequently used following solid organ transplantation, including renal transplantation. Peripheral neuropathy is an uncommon neurological side effect of tacrolimus ...

A 40-year-old woman with a history of chronic graft-versus-host-disease on immunosuppression with tacrolimus presented to the hospital with somnolence, confusion and muscle cramps over a few days. She ...

The FDA based its warning on animal studies. Dermatologists have not seen an increased risk of these cancers in patients who apply tacrolimus (tah-crow-luh-mus) or pimecrolimus (peh-mec-row-lie-mus) ...

(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Keloids. According to GlobalData, Phase I drugs for Keloids does not have sufficient historical data to ...

There have been very few studies using tacrolimus as a novel second line treatment in patients with either steroid refractory or intolerant disease. Methods The authors performed a retrospective ...

(Plerixafor + tacrolimus) is under clinical development by MedRegen and currently in Phase I for Spinal Cord Injury. According to GlobalData, Phase I drugs for Spinal Cord Injury does not have ...

Aim: Little information is available regarding the influence of CYP3A5 genetic polymorphisms on tacrolimus dose requirement in pediatric liver transplantation. Patients & methods: We performed a ...

United States, Phoenix, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Glenmark Pharmaceuticals announced that it received final approval from the United States Food and Drug Administration (U.S. FDA) for its 0.03 ...

kochi-u.ac.jp Background The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal ...

yahoo.com Objective To compare the efficacy of tacrolimus (TAC) and mycophenolate mofetil (MMF) for the initial therapy of lupus nephritis (LN). Study design This is an open randomised controlled ...